Inter Parfums Earnings: What To Look For From IPAR

Inter Parfums (NASDAQ: IPAR) reports earnings Tuesday after market close. Last quarter, it posted revenue of $344.9 million, up 1.8% YoY, meeting revenue expectations, with EPS beating estimates but gross margin missing. For the current quarter, analysts expect 1.5% YoY revenue growth. The article cites an average price target of $125.80 versus $124.55.

Original reporting
Published Aug 3, 2026, 5:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 5:44 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Inter Parfums Earnings: What To Look For From IPAR — source image
Decision brief

The 30-second read

$IPARNeutralMed
01

Why it matters

Traders can use the gross margin miss and the modest consensus revenue growth reversal to form scenarios for the earnings reaction, but the article does not add new company-specific disclosures beyond the upcoming timing.

02

Market read

This is primarily an earnings timing and expectation setup for IPAR, with peer results used as informal context.

03

What to watch

The preview does not discuss guidance, channel inventory, pricing, or cost drivers that typically determine post-earnings moves.

Relevance 4/10Novelty 4/10Timing: Ahead of IPAR earnings Tuesday after the close.

Background

The piece is a pre-earnings checklist for Inter Parfums, citing last quarter’s revenue beat and gross margin miss, plus consensus revenue growth expectations.

Company-level read

Ticker impact

$IPARNeutralMedium confidence
Context

Inter Parfums is set to report earnings Tuesday after the close, with prior-quarter revenue and gross margin misses shaping expectations.

Expected impact

Likely elevated volatility into the print, with direction dependent on whether gross margin stabilizes versus the prior miss.

Evidence & confidence

No new guidance or results are disclosed here; it is a pre-earnings preview using previously reported revenue/EPS and gross margin outcomes plus consensus growth expectations.

Market effects

Consumer staples and fragrance peers are referenced as read-through, but the article does not provide new fundamentals for the sector.

None specified.

None specified.

Counterpoint

If IPAR’s gross margin miss was transitory, the market may focus more on revenue growth and EPS beat history than margin weakness.

Key entities

  • Inter Parfums

    NASDAQ-listed fragrance and perfume company reporting earnings Tuesday after the close.

  • Vita Coco

    Peer cited for Q2 read-through after a reported revenue beat and subsequent stock drop.

  • WD-40

    Peer cited for Q2 read-through after reported revenue outperformance and stock rise.

Related articles

$IPARMed

Inter Parfums (NASDAQ:IPAR) Posts Better

Inter Parfums (NASDAQ:IPAR) reported Q2 CY2026 revenue of $341 million, up 2.1% year on year and 0.6% above market expectations, according to the company. Full-year revenue guidance was $1.48 billion at the midpoint, 1.5% below analysts’ estimates. GAAP EPS was $0.95, 2.1% below consensus. The stock was flat at $128.43 after results.

$IPARMed

INTERPARFUMS INC (IPAR): Results of Operations and Financial Condition

INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 7 ex991_1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INTERPARFUMS, INC. REPORTS 2026 SECOND QUARTER NET SALES 2026 Second Quarter Conference Call Scheduled for August 5, 2026 New York, New York, July 22, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums”

$NVDAMed

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Broadcom, Microsoft, IBM, Meta, Tyson Foods & more

Wall Street analysts issued multiple calls Monday. Goldman initiated HawkEye 360 as buy; Morgan Stanley upgraded Dell to equal weight; Wells Fargo upgraded Tandem Diabetes Care to overweight. Citizens initiated Microsoft at Market Outperform with a $550 target; Barclays initiated IBM at overweight with a $350 target. Cantor reiterated Tesla overweight; RBC reiterated Meta outperform. Broadcom was reiterated overweight by Morgan Stanley, raising its target to $485.